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In order to define mechanisms regulating the synthesis of procollagenase in human rheumatoid synovial 
libroblasts, the proteins synthesized by cultured cells were labeled with [YS]methionine. Labeled medium 
proteins were analyzed by SDS-PAGE directly and after immunocomplexing with a specific antibody to 
human libroblast collagenase. Labeling of both the predominant form of the enzyme (Mr- 55 000) as well 
as a minor species (Mr - 61000) was increased following incubation with the monokine, mononuclear cell 
factor/interleukin 1. The -61 kDa form of the procollagenase appears to be a glycosylated form of the 
- 55 kDa precursor based on binding to Con A-Sepharose and decrease in the - 61 kDa form after culture 
in the presence of tunicamycin. Thus, mononuclear cell factor, homologous with interleukin 1, partially pu- 
rified from monocyte conditioned medium increas f mcorporation of [35S]methionine into several medium 
proteins, including those complexed by the anticollagenase antibody. In the presence of mononuclear cell 
factor/interleukin 1, labeling of the procollagenase was increased 12-14-fold over control cultures incubated 
with medium alone. Therefore, one of the mechanisms involved in increase of collagenase activity in the 
medium of cultured synovial libroblasts in the presence of mononuclear cell factor/interleukin 1 is a stimula- 
tion of enzyme protein synthesis. 
Procollagenase Synovialfibroblast Mononuclear cell factor Interleukin I 
1. INTRODUCTION 
Animal collagenases initiate the degradation of 
collagen by a specific and limited cleavage across 
the 3 chains that comprise the collagen moIecuIes 
in solution or in fibrils. These enzymes appear to 
play a role in the turnover of several connective 
tissues [l-3]. Collagenolysis is regulated at several 
levels including transcription of procollagenase 
genes, packaging and secretion of newly synthe- 
sized procollagenase, activation of the procol- 
lagenase and regulation of the activity of the active 
enzyme by specific inhibitors [3]. 
We have demonstrated that rheumatoid synovial 
fibroblasts are the major source of procollagenase 
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[4,5]. When these cells are cultured the levels of 
procollagenase, measured after activation with 
trypsin, decrease but can be restored by incubation 
of the cultured cells with a soluble factor, termed 
mononuclear cell factor (MCF), secreted by 
monocyte/macrophages [5-71. This factor which 
has been partially purified [8] is probably identical 
to interleukin 1 (ILl) [9,101. 
The present studies were designed to determine 
whether the increased level of collagenase activity 
in medium conditioned by the rheumatoid synovial 
cells stimulated with MCF is accounted for by in- 
creased synthesis of enzyme, increased secretion Of 
stored enzyme, or modification of enzyme to in- 
crease its enzyme activity. By measuring incor- 
poration of [3sS]methionine into secreted proteins 
as well as those immunocomplexed with a specific 
antibody to collagenase, we have obtained 
evidence that MCF stimulates synthesis of pro- 
collagenase in synovial target cells. 
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2. MATERIALS AND METHODS 
2.1. Cell culture and preparation of MCF 
Cultures of human rheumatoid synovial 
fibroblasts were prepared from samples of 
synovium obtained at time of surgery from pa- 
tients with rheumatoid arthritis as described [4,11]. 
Cells in the first or second passage at a density of 
1 x lo6 cells per 10 cm dish cultured in Dulbecco’s 
modification of Eagle’s medium (DME medium, 
Gibco) containing 10% fetal calf serum, were ex- 
posed to MCF for 48 h prior to the addition of 
[35S]methionine. Following removal of the serum- 
containing DME medium, [35S]methionine was 
added in methionine free-DME medium at 
25-50 &i/ml in a total volume of 5 ml per 100 cm 
diameter culture dish. Labeled medium was 
aspirated following 24 h of incubation, unless 
noted otherwise, then centrifuged at 3000 rpm for 
15 min and the supernatant stored at -20°C. 
MCF was prepared from peripheral blood 
monocytes and partially purified on columns of 
Ultrogel AcA54 as in [8]. Only mononuclear cells 
adhering to plastic culture dishes after 1 h incuba- 
tion and extensive washing were utilized. The 
amount of MCF utilized here was arbitrarily 
chosen on the basis of stimulation of collagenase 
by rheumatoid synovial fibroblasts, measured 
after activation with trypsin [l 1,121. 
2.2. Preparation of anticollagenase antibody 
Rabbit antibody to human skin fibroblast pro- 
collagenase [13,141 was generously provided by Dr 
Eugene Bauer, Washington University, St. Louis, 
MO. The immunoglobulin fraction was purified by 
passing 1 ml of the antibody-containing rabbit 
serum diluted 1: 1 with phosphate-buffered saline 
(PBS) over a column of protein A-Sepharose 
CL-4B (Sigma, St. Louis, MO) and eluting the im- 
munoglobulin with 0.1 M glycine, pH 3.0. The im- 
munoglobulin fraction was dialyzed against PBS, 
containing 0.02% sodium azide, and concentrated 
to 125 pug/ml in an Amicon apparatus using a 
UM-10 filter (Amicon, Lexington, MA). 
2.3. Immunocomplexing of procollagenase 
After labeling of synovial cell cultures with 
[35S]methionine, cell free-medium (100-200 ~1) 
was incubated with 300 ~1 PBS containing 0.1% 
Triton X-100,0.1% bovine serum albumin and an- 
8 
tibody, 125 pg/ml, for 1 h at 37°C and an addi- 
tional 12-14 h at 4°C. Immune complexes were 
harvested by the addition of 75 ~1 of a 10% 
suspension of inactivated Staphylococcus aureus 
cells(Cowan I strain) as a source of immobilized 
protein A (IgGSORB, The Enzyme Center, 
Boston, MA) in incubation buffer. The IgGSORB 
immunocomplexes were washed 3 times with in- 
cubation buffer, before the addition of SDS- 
PAGE sample buffer containing 5% p- 
mercaptoethanol. The samples were then heated to 
90°C for 3 min and centrifuged prior to SDS- 
PAGE. 
2.4. Binding of proteins to Con A-Sepharose 
Columns were prepared using siliconized glass 
tubes (0.5 cm diameter). In most experiments 
1.5 ml Con A-Sepharose (Pharmacia, Piscataway, 
NJ) was added, and columns equilibrated with 
PBS. The labeled sample (0.25 ml) was added 
followed by PBS and the unbound fraction, usual- 
ly in a volume of 2.5 ml, collected. Following 
washing with 6 x the bed volume the bound frac- 
tion was eluted with -2 ml of 0.5 M CZ- 
methylmannoside. These samples were then 
analyzed by SDS-PAGE with or without prior 
complexing with antihuman collagenase im- 
munoglobulin as described above. 
2.5. Electrophoretic analysis of labeled proteins 
Standard discontinuous SDS-PAGE was per- 
formed [15] either with 12.5% polyacrylamide gels 
or lo-15% linear gradient gels, run at 12-16 mA 
for 16-18 h at room temperature. Fluorograms of 
the gels were prepared as described [ 161. To quan- 
titate radioactivity, in some experiments bands 
corresponding to the radioautographs were cut 
from the dried slab gels extracted with NCS tissue 
solubilizer (Amersham/Searle, Arlington Heights, 
IL) and counted using a Packard Tricarb liquid 
scintillation counter. 
2.6. Measuremenr of collagenase activity 
Procollagenase was activated with 5-25 /cg 
TPCK trypsin (Worthington, Freehold, NJ) per 
100~1 cultured medium for 15 min at 20°C. A 
3-fold excess of soybean trypsin inhibitor (Wor- 
thington) was then added to stop the reaction 
[4,11]. Viscometric assays [17] were performed 
with 1 ml capacity viscometers with flow times for 
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water of 33 s at 27°C. A volume of the activated function of time was increased -lO-fold in 
sample (100 /cl) was then added to a reaction mix- medium from cells incubated with MCF compared 
ture containing 200,ul rat tail tendon collagen to cells incubated with DME medium alone. The 
(3 mg/ml) and 700 pl of 0.1 M Tris-HCl, pH 7.6, specificity of the antibody for collagenase was con- 
containing 0.15 M NaCl and 0.005 M CaC12. firmed by the complete inhibition of collagenase 
Purified immunoglobulin (125 pg) was added to activity by the addition of the anticollagenase an- 
the reaction mixture as indicated. tibody as measured by no further decrease in qsp. 
2.7. Reagents 
f3’S]Methionine (spec. act. 1200-1400 Ci/ 
mmol) was purchased from Amersham/Searle. 
Tunicamycin and cu-methyl-D-mannoside were 
purchased from Sigma. 
3. RESULTS 
The effect of pre-incubation with MCF on the 
synthesis of labeled proteins by synovial 
fibroblasts is shown in fig.2A. An increase in the 
synthesis of several different proteins was ob- 
served. The stimulation appeared to be selective, 
since the labeling of all proteins was not increased 
to the same degree. The results of immunocom- 
plexing of labeled medium with the antibody to 
Synovial fibroblasts incubated with the MCF 
preparation used in the labeling experiments in- 
creased the release of latent collagenase activity in- 
to medium as shown in the viscometric assay 
described in fig.1. A viscometric assay was used 
because the relatively large amount of radioactivity 
present in medium from cells incubated with 
[35S]methionine would obscure measurement of 
solubilization of radioactively labeled collagen 
fibrils utilized for most collagenase assays. The 
change in the slope of specific viscosity (asp) as a 
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Fig.1. Effect of incubation with MCF on collagenase 
activity released by synovial fibroblasts. Synovial 
fibroblasts in second passage were incubated with (+ ) or 
without (-) MCF. An aliquot of the cell-free culture 
medium (100 ~1) was then activated with TPCK trypsin 
as described. The activated medium was then added to 
a solution of rat tail tendon collagen and specific 
viscosity (vsp) determined at the intervals indicated. At 
the time indicated by the arrows the purified 
immunoglobulin fraction (125 fig) of the rabbit 
Fig.2. Effect of MCF on incorporation of 
[35S]methionine into procollagenase and other proteins 
analyzed by SDS-PAGE and fluorography. Cells were 
incubated for 48 h with (+) (lanes 2,4,5) or without (-) 
(lanes 1,3) MCF, following which [35S]methionine was 
added as described. (A) Total medium proteins. (B) 
Proteins complexed to antihuman collagenase immu- 
noglobulin (lanes 3,4) or nonspecific immunoglobulin 
(lane 5). In medium from’the MCF-stimulated cultures 
the major ‘complexed proteins had Mr -55000 (a) in 
addition to other components with M, -61000 (b) and 
-49000 (c). A marked increase in labeling of these 
proteins was observed in medium from cultures prein- 
antihuman collagenase was added. cubated with MCF. 
9 
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procollagenase are shown in fig.2B. There was a 
marked enhancement of the labeling of proteins 
complexed with the antibody from the medium of 
cells incubated with MCF. 
The major labeled band was of Mr -55000 in 
addition to a more slowly migrating band of Mr 
-61000. Another minor species was also seen of 
it4, -45000; the intensity of labeling of this band 
was variable, but it appeared to be more prominent 
in samples stored for long periods even at - 20°C. 
The direct addition of Trasylol (aprotinin), a 
serum protease inhibitor, to synovial cell cultures 
did not change the relative labeling of the proteins 
in the range Mr -55000-61000, suggesting that 
proteolytic cleavage by serine proteases was not 
responsible for the multiplicity of proteins of this 
apparent size (not shown). 
To investigate the possibility that the several 
proteins complexed by the collagenase antibody 
could result from the presence of glycosylated 
forms of the enzyme, medium from synovial cell 
cultures stimulated with MCF was chromato- 
graphed on Con A-Sepharose. The results are 
shown in fig.3. Several proteins did not bind to the 
Con A-Sepharose column whereas others were 
bound and could be eluted with 0.5 M m-methyl 
mannoside. When the bound and unbound frac- 
tions were incubated with the anticollagenase an- 
tibody and analyzed by SDS-PAGE it was found 
that the major procollagenase species of MI 
-55000 did not bind to the Con A-Sepharose col- 
umn, whereas the minor species of A4, -61000 did 
(fig.3B). These results are consistent with the inter- 
pretation that the major secreted procollagenase 
from stimulated and unstimulated human synovial 
cells is not glycosylated, but that the minor higher- 
M, species is glycosylated. The apparent hetero- 
geneity in the labeling of the procollagenase is 
therefore due, at least in part, to varying degrees of 
glycosylation. 
Further evidence for glycosylation of the pro- 
collagenase was obtained by studies utilizing 
tunicamycin. As shown in fig.4A, in synovial cell 
cultures incubated with or without MCF, the 
simultaneous presence of tunicamycin resulted in a 
general shift of bands to those with lower MI as 
well as a mild decrease in synthesis of all proteins. 
In cultures treated with tunicamycin, however, a 
decrease in the Mr -61 kDa procollagenase species 
complexed with antibody was accompanied by an 
10 
Fig.3. Binding to Con A-Sepharose of labeled proteins 
from the medium of synovial fibroblasts incubated with 
MCF, analysed by SDS-PAGE. Conditions were as 
described in section 2. Pattern of labeled proteins before 
addition to Con A-Sepharose (lane 1,4), fractions which 
did not bind to Con A-Sepharose (lanes 2,5) and 
fractions which bound and could be eluted with 0.5 M cy- 
methylmannoside (lanes 3,6). (A) Samples analyzed by 
SDS-PAGE without incubation with antibody. (B) 
Samples complexed with antihuman collagenase 
immunoglobulin. Note that the major protein 
complexed by the antihuman collagenase immuno- 
globulin, of M, -55000 (a), did not bind to Con A- 
Sepharose, whereas the components of M, -61000 (b) 
and -49000 (c) were bound and eluted with 0.5 M cy- 
methylmannoside. 
increase in the amount of -55 kDa procollagenase 
species (fig.4B). These observations suggest hat 
the -55 kDa form is a precursor of a -61 kDa 
glycosylated form. The apparently glycosylated 
form of the procollagenase comprised -23-25070 
of the total labeled collagenase as estimated by cut- 
ting appropriate sections of the SDS-PAGE gel, 
extracting and counting the radioactivity. When 
the activity of nonglycosylated and glycosylated 
forms of the enzyme in medium from cells not in- 
cubated with [3’S]methionine was measured in a 
collagen fibril assay [4], the glycosylated form ac- 
counted for -25-28% of the total collagenase ac- 
tivity (not shown). 
Experiments were next designed to determine the 
kinetics of the MCF effect on stimulation of pro- 
collagenase synthesis. In medium from cells prein- 
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Fig.4. Effects of tunicamycin on proteins synthesized by 
rheumatoid synovial fibroblasts incubated with or 
without MCF. Cells were incubated for 48 h with (+) 
(lanes 2,4,6,8) or without (-) (lanes 1,3,5,7) MCF. 
Tunicamycin was then added to samples (shown in lanes 
3,4,7,8) at 44 h. [3’S]Methionine was then added at 48 h 
to all samples and incubation continued for 24 h. 
Medium proteins were then analyzed by SDS-PAGE. 
(A) Patterns of labeled medium proteins from cell-free 
medium of samples not incubated with antibody. (B) 
Corresponding samples as in A, but complexed with 
antihuman collagenase immunoglobulin. Note that the 
major protein complexed by the antihuman collagenase 
immunoglobulin of A4, -55000 (a) persisted after 
incubation with tunicamycin whereas the protein of h4, 
-61000 (b) could no longer be detected. The protein of 
IU, -49000 (c) decreased and a new band appeared at M, 
-41000 (d). 
cubated with MCF, procollagenase in the medium 
was detected within 2 h after the addition of 
radioactive methionine, as shown in fig.5. The rate 
of synthesis of procollagenase appeared to fall off 
by 24 h of incubation. These observations are con- 
sistent with little or no intracellular storage of the 
newly synthesized procollagenase in these human 
synovial cells. The increase in labeling of the major 
55 kDa procollagenase protein by cells incubated 
with MCF ranged from 12- to 16fold over that of 
cells incubated with DME medium alone at 2, 4 
and 8 h after addition of [“Slmethionine (fig.5). 
When MCF and [35S]methionine were added 
simultaneously to synovial fibroblast cultures, 
significant amounts of labeled complexed protein 
were not detected until 18 h later (not shown). 
4. DISCUSSION 
We have previously demonstrated that 
MCF/ILl increases the levels of collagenase activi- 
ty (measured following activation of latent enzyme 
with trypsin) in medium from human rheumatoid 
synovial fibroblast cultures [ 1,5,6-g]. The present 
results indicate that MCF/ILl increases the syn- 
thesis of procollagenase. Incubation with the MCF 
preparation used here also increased [‘-%I- 
methionine incorporation into several other pro- 
teins with h& ranging from -40000 to 70000 the 
identity of which has yet to be established. We 
have also observed in other studies that MCF in- 
creases the synthesis of several macromolecules 
such as type I and III procollagens and fibronectin 
[121. 
The exact mechanism of the MCF/ILl effect to 
increase procollagenase levels remains to be 
elucidated. In other systems in which collagenase 
synthesis has been studied such as cultures of rab- 
bit synovial cells, the addition of phorbol myristate 
acetate or monosodium urate crystals increases 
procollagenase protein synthesis as well as the level 
of translatable hybridizable procollagenase mRNA 
consistent with transcriptional control of pro- 
0 4 6 12 16 20 24 
lwlws 
Fig.5. Time course of effect of MCF preincubation on 
labeling of major procollagenase protein. Conditions 
were those described in fig.2, except that samples were 
removed at indicated times and proteins resolved by 
SDS-PAGE. The band corresponding to the major 
procollagenase species (k& -55000) was cut from the 
dried gel, extracted with NCS solubilizer and counted in 
a liquid scintillation counter. 
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collagenase synthesis [18-211. The present results 
would be compatible with such a control 
mechanism. Although only partially purified 
preparations of MCF/ILl were used here, it has 
now been shown that at least one recombinant 
DNA form of IL1 [22] increases medium levels of 
collagenase activity [23]. It is therefore likely that 
the stimulatory effects observed here are due to 
ILl. 
[31 
[41 
The antibody to human skin fibroblast pro- 
collagenase used here complexed predominantly 2 
forms of human rheumatoid fibroblast pro- 
collagenase, with M, -55000 and -61000, both of 
which were active enzymatically. These 2 forms 
could be separated on Con A-Sepharose columns. 
The major -55 kDa species, comprising approx. 
75% of the total procollagenase, appeared to be 
nonglycosylated. The minor species, whose label- 
ing was abohshed by the addition of tunicamycin, 
was likely a glycosylated form of the -55 kDa 
precursor. Similar conclusions were derived from 
observations of cultured rabbit synovial fibro- 
blasts [21]. MCF/ILl increases the synthesis of 
both forms of the enzyme. This increase in syn- 
thesis in cells preincubated with IL1 was detected 
within 2 h of addition of the labeled amino acid. 
The monokine MCF/ILl thus has several pro- 
found effects on the function of the synovial 
fibroblasts. It remains to be shown how this 
stimulation of procollagenase synthesis is 
mediated. 
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